“Bevacizumab in Advanced High Grade Serous Ovarian Cancer: The Impact of BRCA Mutation Status”, J. Can. Res. Updates, vol. 15, no. 1, pp. 1–10, Jan. 2026, doi: 10.30683/1929-2279.2026.15.01.